Spyre Therapeutics To Participate In Upcoming Investor Conferences
Event : UBS Global Biopharma Conference – London
Date: Monday, November 16, 2026
Fireside Time: 1:20 pm GMT
Event: Jefferies Global Healthcare Conference – London
Date: Tuesday, November 17, 2026
Fireside Time: 3:00 pm GMT
Event: 9th Annual Evercore Healthcare Conference - Miami
Date: Tuesday, December 1, 2026
Fireside Time: 3:00 pm ET
Event: Citi's 2026 Global Healthcare Conference - Miami
Date: Wednesday, December 2, 2026
Fireside Time: 9:40 am ET
Members of the Spyre management team will also host one-on-one investor meetings during the conferences.
Live audio webcasts and replays of these events will be available on the Spyre investor events website at .
About Spyre Therapeutics
Spyre Therapeutics is a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, IL-23, and IL-17A/F as well as rational combination programs.
For more information, visit Spyre's website at
For Investors:
Eric McIntyre, Spyre Therapeutics
SVP of Finance and Investor Relations
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment